Liwei Li, director, chief physician, professor and doctoral supervisor of nuclear medicine department (including PET/CT diagnosis center) of Air Force Medical Center

Expertise: He has high academic accomplishment and reputation in the field of radionuclide therapy, especially in radiographic diagnosis (CT, MRI) and nuclear medical imaging diagnosis (PET, SPECT).

Social appointments: A member of the Expert Database of Medical Malpractice Appraisal Committee of Chinese Medical Association, a member of Young and Middle-aged Committee of Chinese Society of Nuclear Medicine, a member of the editorial committee and editorial review group of Chinese Journal of Nuclear Medicine, the standing director of Chinese Medical Imaging Technology Association, the deputy director of Nuclear Medicine Branch of Chinese Medical Imaging Technology Association, a member and secretary of Nuclear Medicine Specialty Committee of Beijing Medical Association, the standing member and secretary of Nuclear Medicine Specialty Committee of the Army, a member of editorial board of Chinese Journal of Medical Imaging Technology, a member of editorial board of Chinese Journal of Nuclear Medicine Forum for Youth, a member of Proposition Committee of Medical and Health Professional and Technical Title Examination of the Army.

Achievements: He has received X-ray CT and MRI technology training at California State University, Los Angeles of the United States. He has rich experience in clinical practice of radiographic imaging diagnosis and nuclear medical imaging diagnosis, and has obtained senior technical title certificates of the majors of radiographic imaging diagnosis (CT, MRI) and nuclear medical imaging diagnosis (PET, SPECT) of the Army, respectively. From 1983 to 1998, during the period of engaging in the clinical diagnosis and scientific research of X-ray CT and MRI imaging, he has successively won a total of 6 awards including the third and fourth prizes for scientific and technological progress achievements of the Army in the fields of X-ray CT and MRI imaging. In 1998, he started to engage in the clinical application research of PET/CT, SPECT/CT imaging (nuclear medicine molecular imaging technologies), and accumulated clinical experience in PET and PET/CT imaging of more than 5,000 cases of malignant tumors. In particular, he has conducted in-depth research on the complementary advantages and comprehensive application of nuclear medical imaging methods such as PET, PET/CT, SPECT/CT and X-ray CT and MRI methods in the clinical diagnosis and treatment of various malignant tumors. He officially published more than 50 academic papers on X-ray CT, MRI, PET and PET/CT in the journals such as Chinese Medical Journal and the National Statistical Source Core Journal as the first author, and won the first prize of Excellent Paper at National Academic Conferences for three times. He has participated in the compilation of more than 10 academic books for nuclear medical imaging diagnosis such as X-ray CT, MRI imaging diagnosis and PET.